Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;8(1):92-99.
doi: 10.1016/j.sxmr.2019.03.003. Epub 2019 Apr 12.

Topical Agents for Premature Ejaculation: A Review

Michael J Butcher  1 , Tricia Zubert  2 , Kristin Christiansen  2 , Alejandro Carranza  2 , Paul Pawlicki  2 , Stacey Seibel  2
Affiliations
Review

Topical Agents for Premature Ejaculation: A Review

Michael J Butcher et al. Sex Med Rev. 2020 Jan.

Abstract

Introduction: Premature ejaculation (PE) is among the most common sexual dysfunctions that affect men. Currently, topical medications are considered a first-line treatment option for PE, with no specific medication having market approval in the United States specifically for the treatment of PE. Topical agents for PE include eutectic mixture of local anesthetics cream, topical eutectic mixture for premature ejaculation spray, severance secret-cream, resiniferatoxin, and an assortment of over-the-counter treatments, including medicated condoms, sprays, and wipes.

Aim: Given the paucity of controlled studies for these treatment modalities, the goal of this article is to review the currently available options for PE to help educate providers in appropriate treatment options.

Methods: Comprehensive review of published literature, as well as clinical experience were evaluated to determine efficacy of known treatments for PE.

Main outcome measure: The topical treatment options and efficacy of these options for PE were reviewed. Eutectic mixture of local anesthetics, topical eutectic mixture for premature ejaculation, severance secret-cream, resiniferatoxin, and medicated condoms are the mainstay of treatment. Each has certain risks and benefits associated with use as described, as well as relative cost of use.

Results: Although data supporting the effectiveness of topical agents for PE is limited, prior clinical trials demonstrate increases in timed intravaginal ejaculatory latency time and improved patient-partner sexual satisfaction survey scores on some treatment options.

Conclusion: More research is needed to evaluate efficacy, cost-effectiveness, potential side effects, and benefits of combined medical and psychological intervention for better ejaculatory control. Butcher MJ, Zubert T, Christiansen K, et al. Topical Agents for Premature Ejaculation: A Review. Sex Med Rev 2020;8:92-99.

Keywords: Ejaculatory Dysfunction; Pharmacotherapy; Premature Ejaculation.

PubMed Disclaimer